1. Home
  2. IVVD vs TRX Comparison

IVVD vs TRX Comparison

Compare IVVD & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • TRX
  • Stock Information
  • Founded
  • IVVD 2020
  • TRX 1990
  • Country
  • IVVD United States
  • TRX Canada
  • Employees
  • IVVD N/A
  • TRX N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • TRX
  • Sector
  • IVVD Health Care
  • TRX
  • Exchange
  • IVVD Nasdaq
  • TRX Nasdaq
  • Market Cap
  • IVVD 116.8M
  • TRX 109.5M
  • IPO Year
  • IVVD 2021
  • TRX N/A
  • Fundamental
  • Price
  • IVVD $0.44
  • TRX $0.30
  • Analyst Decision
  • IVVD Strong Buy
  • TRX Strong Buy
  • Analyst Count
  • IVVD 4
  • TRX 2
  • Target Price
  • IVVD $7.89
  • TRX $1.63
  • AVG Volume (30 Days)
  • IVVD 981.7K
  • TRX 534.0K
  • Earning Date
  • IVVD 11-14-2024
  • TRX 01-13-2025
  • Dividend Yield
  • IVVD N/A
  • TRX N/A
  • EPS Growth
  • IVVD N/A
  • TRX N/A
  • EPS
  • IVVD N/A
  • TRX N/A
  • Revenue
  • IVVD $11,564,000.00
  • TRX $41,158,000.00
  • Revenue This Year
  • IVVD N/A
  • TRX $68.64
  • Revenue Next Year
  • IVVD $486.65
  • TRX $32.59
  • P/E Ratio
  • IVVD N/A
  • TRX N/A
  • Revenue Growth
  • IVVD N/A
  • TRX 7.41
  • 52 Week Low
  • IVVD $0.40
  • TRX $0.30
  • 52 Week High
  • IVVD $5.20
  • TRX $0.49
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 29.58
  • TRX 22.91
  • Support Level
  • IVVD $0.57
  • TRX $0.35
  • Resistance Level
  • IVVD $0.51
  • TRX $0.36
  • Average True Range (ATR)
  • IVVD 0.06
  • TRX 0.02
  • MACD
  • IVVD -0.01
  • TRX -0.00
  • Stochastic Oscillator
  • IVVD 13.30
  • TRX 6.67

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About TRX TRX Gold Corporation

TRX Gold Corp, formerly Tanzanian Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. Its projects include the Buckreef project, Kigosi project, and Itetemia Gold project whereas, its exploration stage project consists of the Lunguya project and the Luhala project.

Share on Social Networks: